查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球臨床實驗室服務市場：依檢測類型、地點、產品和國家的策略和趨勢預測 - 附執行顧問指南 - 第8阿宿版（2025-2029年）
市場調查報告書
商品編碼
1764337

全球臨床實驗室服務市場：依檢測類型、地點、產品和國家的策略和趨勢預測 - 附執行顧問指南 - 第8阿宿版（2025-2029年）

Global Clinical Medical Laboratory Services Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides - 8th Edition. 2025 to 2029
出版日期: | 出版商: Howe Sound Research | 英文 373 Pages | 商品交期: 最快1-2個工作天內

價格

臨床實驗室積極應對新冠疫情的挑戰，但疫情的結束也催生了新的診斷方法。即時檢驗和自我檢測威脅臨床實驗室服務的長期需求，而分子診斷則推動其快速成長。閱讀這份全面的報告，了解其中的機會和威脅。

生物技術，尤其是基因體學的爆炸性發展將直接惠及臨床檢測。各種動態趨勢推動市場成長和公司估值。

本報告提供的資料可供分析師和規劃人員使用。報告詳細細分了15個國家和4個地區。購買本報告的用戶均可查看全球任何國家的詳細資料。

所有報告資料可依需求提供 Excel 格式。

目錄

第1章 市場指南

  • 策略情勢分析
  • 高階主管、行銷、銷售和業務開發人員指南
  • 管理顧問和投資顧問指南

第2章 簡介與市場定義

  • 新興的臨床檢測需求
  • 機會定義
    • 市場收入規模
  • 研究方法
  • 視角：醫療保健和體外診斷（IVD）行業

第3章 市場動態概覽

  • 市場參與者
    • 學術研究機構
    • 診斷偵測開發商
    • 儀器供應商
    • 藥品和試劑製造商
    • 病理供應商
    • 獨立臨床實驗室
    • 公共國家/地區實驗室
    • 醫院實驗室
    • 臨床實驗室
    • 審核機構
    • 認證機構
  • 細分－各種方法
    • 傳統市場細分
    • 實驗室重點及細分
  • 臨床檢測產業結構
    • 醫院實驗室的市場佔有率
    • 規模經濟的關鍵作用
    • 醫院實驗室的存在
    • 醫師與即時檢驗（POCT）—中國病患服務的復甦
  • 國家和地區多樣性

第4章 驅動市場變化的趨勢

  • 成長受到多種因素的推動
    • 人口結構對消費的影響
    • 新冠疫情相關影響
    • 即時檢驗帶來變革
    • 替代醫學的影響
    • Esoterics
    • 新的實驗領域
  • 市場萎縮的驅動因素
    • 成本去向
    • 人口結構的影響
    • 管理實踐
    • 健康
    • 同類相食
    • 即時檢定
  • 自動化和實驗室的趨勢
    • 傳統的自動化與集中化
    • 新的自動化、分散化和即時檢驗
    • 儀器是市場佔有率的關鍵
    • 生物資訊學發揮重要作用角色
    • PCR 佔據主導地位
    • 新一代定序推動變革
    • NGS 的價格影響
    • 全基因組定序，一個美麗新世界
    • 伴隨診斷模糊了診斷和治療的界限
    • 診斷的角色轉變

第5章 臨床檢測服務的最新趨勢

第6章 主要公司簡介

  • Accel Diagnostics
  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • Aegis Science Corporation
  • American Bio-Clinical Laboratories, Int'l
  • ARUP Laboratories
  • Ascend Clinical
  • Bio-Reference Laboratories
  • Bioscientia Institut fur Medizinische Diagnostik GmbH
  • BP Healthcare Group
  • C2N Diagnostics
  • Clinical Reference Laboratory
  • Clongen Laboratories
  • CompuNet Clinical Laboratories
  • DASA
  • DIAN Diagnostics Co., Ltd.
  • Enzo Biochem
  • Eone Laboratories
  • Eurofins Scientific
  • Exagen Diagnostics
  • Flow Health
  • Fyr Diagnostics
  • Genzyme Corporation
  • Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • Haystack Oncology（Quest Dx）
  • Innoquest Pathology
  • Integrated Regional Laboratories
  • KDL Group
  • Laboratory Corporation of America
  • Lifelabs（Quest）
  • Mayo Clinic Laboratories
  • Medicover
  • Myriad Genetics
  • NeoGenomics
  • OncoDNA
  • Oncohost
  • Prometheus Laboratories
  • ProPhase Labs
  • Psychemedics Corporation
  • Quest Diagnostics
  • SkylineDx
  • Sonic Healthcare
  • Sophia Genetics
  • Spectra Laboratories
  • Streamline Scientific
  • Synlab
  • Sysmex Inostics
  • Unilabs
  • Werfen

第7章 全球臨床實驗室診斷市場

  • 依國家全球市場概覽
  • 依檢測類型全球市場概覽
  • 依地區全球市場概覽
  • 依產品全球市場概覽

第8章 全球臨床實驗室診斷市場類型 - 依檢測類型

  • 化學
  • 微生物學
  • 血液學
  • 解剖病理學
  • 分子診斷學
  • 深奧測試

第9章 全球臨床實驗室診斷市場 - 依地區

  • 住院醫院
  • 門診醫院
  • 獨立實驗室
  • 醫院實驗室
  • 其他

第10章 全球臨床實驗室診斷市場 - 依產品

  • 設備
  • 試劑
  • 人事費用
  • 間接費用
  • 其他

第11章 臨床實驗室的未來

第12章 附錄

  • 美國醫療保險系統：臨床實驗室收費表
  • 最常用的體外診斷試劑檢測
  • 最賺錢的試劑檢測

The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

The report provides data that analysts and planners can use. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. The New Demand for Clinical Testing
  • 2.2. Defining the Opportunity
    • 2.2.1. Revenue Market Size
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Overview of a Dynamic Market

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Segmentation - Different Approaches
    • 3.2.1. Traditional Market Segmentation
    • 3.2.2. Laboratory Focus and Segmentation
  • 3.3. Structure of Clinical Testing Industry
    • 3.3.1. The Hospital Lab - Share of the Pie
    • 3.3.2. Key Role for Economies of Scale
    • 3.3.3. Physician Office Lab's are Still Here
    • 3.3.4. Physician's and POCT - Reviving Patient Service in China
  • 3.4. National and Regional Diversity

4. Trends Driving a Changing Market

  • 4.1. Growth Is Pushed from Many Sides
    • 4.1.1. Demographic Impacts on Consumption
    • 4.1.2. COVID Related Impacts
    • 4.1.3. Point of Care Testing Makes a Difference
    • 4.1.4. Alternative Medicine Effect
    • 4.1.5. Esoterics
    • 4.1.6. A New Laboratory Discipline
  • 4.2. Factors at Work to Shrink the Market
    • 4.2.1. Where are Costs Going?
    • 4.2.2. Population Effects
    • 4.2.3. Management Practices
    • 4.2.4. Wellness
    • 4.2.5. Cannabilization
    • 4.2.6. Point of Care
  • 4.3. Automation and Laboratory Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point Of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Clinical Laboratory Services Recent Developments

  • 5.1. Recent Developments - Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. Source Bioscience Acquires Cambridge Clinical Labs
  • 5.3. Labcorp Acquires Select Assets of BioReference Health
  • 5.4. hc1 + Accumen Launches Clinical Excellence Solutions
  • 5.5. Labcorp enters lab management, services agreement with Inspira Health
  • 5.6. Aventa Genomics Receives Favorable Pricing Determination
  • 5.7. Perseus Completes Acquisition of Matrix Sistemas e Servicos Ltda
  • 5.8. Delve Bio Announces Partnership with Broad Clinical Labs for mNGS
  • 5.9. Quest Dx to Acquire Select Lab Assets from Allina Health
  • 5.10. Eurofins buys Ascend Clinical LLC
  • 5.11. Atalan Sees Potential in Hospital Outreach Business
  • 5.12. Challenge Bringing Routine Testing to Point of Care
  • 5.13. Natera Cites Test Volume Growth, Rosy Reimbursement
  • 5.14. Patients Becoming Stakeholders in Infectious Disease Testing
  • 5.15. MedGenome Acquires Prognosis Laboratories
  • 5.16. Brooks Automation acquires Aim Lab
  • 5.17. Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO
  • 5.18. Mayo Clinic Laboratories and Helix to provide Biopharma Services
  • 5.19. CompuGroup Medical acquires Medicus Laboratory Information Systems
  • 5.20. Quest Diagnostics acquires Summa Health outreach lab
  • 5.21. Q2 Solutions Launches Self-Collection Safety Lab Panel
  • 5.22. Bionano Genomics Announces Launch of Bionano Laboratories
  • 5.23. Labcorp to Spin Off Clinical Development Business
  • 5.24. Value-Based Care Growing More Profitable for Labs
  • 5.25. Lucid Diagnostics Reports Revenue Growth
  • 5.26. NGS Cancer Testing Decision Appeases Industry
  • 5.27. Clinical Labs Make Strong Showing in 2021
  • 5.28. Seegene to Enter Syndromic MDx Space
  • 5.29. EKF Diagnostics Acquires Advanced Diagnostic Laboratory
  • 5.30. Molecular Health, EDGC Ink Liquid Biopsy Partnership
  • 5.31. ProPhase Labs Acquires Nebula Genomics for $14.6M
  • 5.32. Karius Cell-Free DNA Method to Detect Infection Validated
  • 5.33. EDGC Enters Liquid Biopsy Space With Cf DNA
  • 5.34. TruDiagnostic Receives CLIA Certification for Kentucky Laboratory
  • 5.35. Enzo Biochem Q2 Revenues Up 62 Percent
  • 5.36. Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
  • 5.37. FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
  • 5.38. Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
  • 5.39. Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing
  • 5.40. Cooperative Aims to Expand Clinical, Commercial NGS Access

6. Profiles of Key Companies

  • 6.1. Accel Diagnostics
  • 6.2. Acibadem Labmed Laboratory
  • 6.3. ACM Medical Laboratory
  • 6.4. Adicon Clinical Laboratories
  • 6.5. Aegis Science Corporation
  • 6.6. American Bio-Clinical Laboratories, Int'l
  • 6.7. ARUP Laboratories
  • 6.8. Ascend Clinical
  • 6.9. Bio-Reference Laboratories
  • 6.10. Bioscientia Institut fur Medizinische Diagnostik GmbH
  • 6.11. BP Healthcare Group
  • 6.12. C2N Diagnostics
  • 6.13. Clinical Reference Laboratory
  • 6.14. Clongen Laboratories
  • 6.15. CompuNet Clinical Laboratories
  • 6.16. DASA
  • 6.17. DIAN Diagnostics Co., Ltd.
  • 6.18. Enzo Biochem
  • 6.19. Eone Laboratories
  • 6.20. Eurofins Scientific
  • 6.21. Exagen Diagnostics
  • 6.22. Flow Health
  • 6.23. Fyr Diagnostics
  • 6.24. Genzyme Corporation
  • 6.25. Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • 6.26. Haystack Oncology (Quest Dx)
  • 6.27. Innoquest Pathology
  • 6.28. Integrated Regional Laboratories
  • 6.29. KDL Group
  • 6.30. Laboratory Corporation of America
  • 6.31. Lifelabs (Quest)
  • 6.32. Mayo Clinic Laboratories
  • 6.33. Medicover
  • 6.34. Myriad Genetics
  • 6.35. NeoGenomics
  • 6.36. OncoDNA
  • 6.37. Oncohost
  • 6.38. Prometheus Laboratories
  • 6.39. ProPhase Labs
  • 6.40. Psychemedics Corporation
  • 6.41. Quest Diagnostics
  • 6.42. SkylineDx
  • 6.43. Sonic Healthcare
  • 6.44. Sophia Genetics
  • 6.45. Spectra Laboratories
  • 6.46. Streamline Scientific
  • 6.47. Synlab
  • 6.48. Sysmex Inostics
  • 6.49. Unilabs
  • 6.50. Werfen

7. The Global Market for Clinical Laboratory Testing

  • 7.1. Global Market Overview by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Global Market by Country
  • 7.2. Global Market by Assay Type - Overview
    • 7.2.1. Table - Global Market by Assay Type
    • 7.2.2. Chart - Global Market by Assay Type - Base/Final Year Comparison
    • 7.2.3. Chart - Global Market by Assay Type - Base Year
    • 7.2.4. Chart - Global Market by Assay Type - End Year
    • 7.2.5. Chart - Global Market by Assay Type - Share by Year
    • 7.2.6. Chart - Global Market by Assay Type - Segments Growth
  • 7.3. Global Market by Place - Overview
    • 7.3.1. Table - Global Market by Place
    • 7.3.2. Chart - Global Market by Place - Base/Final Year Comparison
    • 7.3.3. Chart - Global Market by Place - Base Year
    • 7.3.4. Chart - Global Market by Place - End Year
    • 7.3.5. Chart - Global Market by Place - Share by Year
    • 7.3.6. Chart - Global Market by Place - Segments Growth
  • 7.4. Global Market by Product - Overview
    • 7.4.1. Table - Global Market by Product
    • 7.4.2. Chart - Global Market by Product - Base/Final Year Comparison
    • 7.4.3. Chart - Global Market by Product - Base Year
    • 7.4.4. Chart - Global Market by Product - End Year
    • 7.4.5. Chart - Global Market by Product - Share by Year
    • 7.4.6. Chart - Global Market by Product - Segments Growth

8. Global Clinical Laboratory Diagnostic Markets - By Assay Type

  • 8.1. Chemistry
    • 8.1.1. Table Chemistry - by Country
    • 8.1.2. Chart - Chemistry Growth
  • 8.2. Microbiology
    • 8.2.1. Table Microbiology - by Country
    • 8.2.2. Chart - Microbiology Growth
  • 8.3. Hematology
    • 8.3.1. Table Hematology - by Country
    • 8.3.2. Chart - Hematology Growth
  • 8.4. Anatomic Pathology
    • 8.4.1. Table Anatomic Pathology - by Country
    • 8.4.2. Chart - Anatomic Pathology Growth
  • 8.5. Molecular Diagnostics
    • 8.5.1. Table Molecular Diagnostics - by Country
    • 8.5.2. Chart - Molecular Diagnostics Growth
  • 8.6. Esoteric
    • 8.6.1. Table Esoteric - by Country
    • 8.6.2. Chart - Esoteric Growth

9. Global Clinical Laboratory Diagnostic Markets - By Place

  • 9.1. In Patient Hospital
    • 9.1.1. Table In Patient Hospital - by Country
    • 9.1.2. Chart - In Patient Hospital Growth
  • 9.2. Out Patient Hospital
    • 9.2.1. Table Out Patient Hospital - by Country
    • 9.2.2. Chart - Out Patient Hospital Growth
  • 9.3. Independent Laboratory
    • 9.3.1. Table Independent Laboratory - by Country
    • 9.3.2. Chart - Independent Laboratory Growth
  • 9.4. Physicians Office Laboratory
    • 9.4.1. Table Physicians Office Laboratory - by Country
    • 9.4.2. Chart - Physicians Office Laboratory Growth
  • 9.5. Other Laboratory
    • 9.5.1. Table Other Laboratory - by Country
    • 9.5.2. Chart - Other Laboratory Growth

10. Global Clinical Laboratory Diagnostic Markets - By Product

  • 10.1. Instruments
    • 10.1.1. Table Instruments - by Country
    • 10.1.2. Chart - Instruments Growth
  • 10.2. Reagents
    • 10.2.1. Table Reagents - by Country
    • 10.2.2. Chart - Reagents Growth
  • 10.3. Labour
    • 10.3.1. Table Labour - by Country
    • 10.3.2. Chart - Labour Growth
  • 10.4. Overhead
    • 10.4.1. Table Overhead - by Country
    • 10.4.2. Chart - Overhead Growth
  • 10.5. Other Product
    • 10.5.1. Table Other Product - by Country
    • 10.5.2. Chart - Other Product Growth

11. The Future of the Clinical Laboratory

12. Appendices

  • 12.1. United States Medicare System: Clinical Laboratory Fees Schedule
  • 12.2. The Most Used IVD Assays
  • 12.3. The Highest Grossing Assays

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Clinical Laboratory Departments and Segments
  • Table 3: Laboratory Management Focus - Different Approaches
  • Table 4: Key Segmentation Variables Going Forward
  • Table 5: Factors Affecting Local Clinical Testing Demand
  • Table 6: Seven Factors Driving Growth
  • Table 7: Alternative Medicine Segments
  • Table 8: Six Factors Limiting Growth
  • Table 9: Seven Key Diagnostic Laboratory Technology Trends
  • Table 10: Global Market by Region
  • Table 11: Global Market by Assay Type
  • Table 12: Global Market by Place
  • Table 13: Global Market by Product
  • Table 14: Chemistry by Country
  • Table 15: Microbiology by Country
  • Table 16: Hematology by Country
  • Table 17: Anatomic Pathology by Country
  • Table 18: Molecular Diagnostics by Country
  • Table 19: Esoteric by Country
  • Table 20: In Patient Hospital by Country
  • Table 21: Out Patient Hospital by Country
  • Table 22: Independent Laboratory by Country
  • Table 23: Physicians Office Laboratory by Country
  • Table 24: Other Laboratory by Country
  • Table 25: Instruments by Country
  • Table 26: Reagents by Country
  • Table 27: Labour by Country
  • Table 28: Overhead by Country
  • Table 29: Other Product by Country
  • Table 30: Clinical Lab Fee Schedule
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays

Table of Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: The Road to Diagnostics
  • Figure 3: The Changing Age of The World's Population
  • Figure 4: Health Care Consumption by Age
  • Figure 5: Cancer Incidence - Age at Diagnosis
  • Figure 6: Centralized vs. Decentralized Laboratory Service
  • Figure 7: A Highly Multiplexed Syndromic Testing Unit
  • Figure 8: The Real Cost to Sequence the Human Genome
  • Figure 9: The Codevelopment Process
  • Figure 10: Comparing MDx Diagnostic and Traditional Testing
  • Figure 11: Global Market Pareto Chart
  • Figure 12: Global Market by Assay Type - Base vs. Final
  • Figure 13: Global Market by Assay Type Base Year
  • Figure 14: Global Market by Assay Type End Year
  • Figure 15: Assay Type Share by Year
  • Figure 16: Assay Type Segments Growth
  • Figure 17: Global Market by Place - Base vs. Final
  • Figure 18: Global Market by Place Base Year
  • Figure 19: Global Market by Place End Year
  • Figure 20: Place Share by Year
  • Figure 21: Place Segments Growth
  • Figure 22: Global Market by Product - Base vs. Final
  • Figure 23: Global Market by Product Base Year
  • Figure 24: Global Market by Product End Year
  • Figure 25: Product Share by Year
  • Figure 26: Product Segments Growth
  • Figure 27: Chemistry Growth
  • Figure 28: Microbiology Growth
  • Figure 29: Hematology Growth
  • Figure 30: Anatomic Pathology Growth
  • Figure 31: Molecular Diagnostics Growth
  • Figure 32: Esoteric Growth
  • Figure 33: In Patient Hospital Growth
  • Figure 34: Out Patient Hospital Growth
  • Figure 35: Independent Laboratory Growth
  • Figure 36: Physicians Office Laboratory Growth
  • Figure 37: Other Laboratory Growth
  • Figure 38: Instruments Growth
  • Figure 39: Reagents Growth
  • Figure 40: Labour Growth
  • Figure 41: Overhead Growth
  • Figure 42: Other Product Growth